233 related articles for article (PubMed ID: 28614368)
1. Barriers and facilitators of adherence to antidepressants among outpatients with major depressive disorder: A qualitative study.
Ho SC; Jacob SA; Tangiisuran B
PLoS One; 2017; 12(6):e0179290. PubMed ID: 28614368
[TBL] [Abstract][Full Text] [Related]
2. Toward a cultural adaptation of pharmacotherapy: Latino views of depression and antidepressant therapy.
Vargas SM; Cabassa LJ; Nicasio A; De La Cruz AA; Jackson E; Rosario M; Guarnaccia PJ; Lewis-Fernández R
Transcult Psychiatry; 2015 Apr; 52(2):244-73. PubMed ID: 25736422
[TBL] [Abstract][Full Text] [Related]
3. The association of race, comorbid anxiety, and antidepressant adherence among Medicaid enrollees with major depressive disorder.
Wu CH; Erickson SR; Piette JD; Balkrishnan R
Res Social Adm Pharm; 2012; 8(3):193-205. PubMed ID: 21955808
[TBL] [Abstract][Full Text] [Related]
4. Variables influencing antidepressant medication adherence for treating outpatients with depressive disorders.
Lee MS; Lee HY; Kang SG; Yang J; Ahn H; Rhee M; Ko YH; Joe SH; Jung IK; Kim SH
J Affect Disord; 2010 Jun; 123(1-3):216-21. PubMed ID: 19914719
[TBL] [Abstract][Full Text] [Related]
5. Patients' perspective of barriers and facilitators to taking long-term controller medication for asthma: a novel taxonomy.
Peláez S; Lamontagne AJ; Collin J; Gauthier A; Grad RM; Blais L; Lavoie KL; Bacon SL; Ernst P; Guay H; McKinney ML; Ducharme FM
BMC Pulm Med; 2015 Apr; 15():42. PubMed ID: 25907709
[TBL] [Abstract][Full Text] [Related]
6. A qualitative study on healthcare professionals' perceived barriers to insulin initiation in a multi-ethnic population.
Lee YK; Lee PY; Ng CJ
BMC Fam Pract; 2012 Jul; 13():28. PubMed ID: 22469132
[TBL] [Abstract][Full Text] [Related]
7. Adherence during antiviral treatment regimens for chronic hepatitis C: a qualitative study of patient-reported facilitators and barriers.
Evon DM; Golin CE; Bonner JE; Grodensky C; Velloza J
J Clin Gastroenterol; 2015; 49(5):e41-50. PubMed ID: 24828358
[TBL] [Abstract][Full Text] [Related]
8. Qualitative Analysis of Barriers and Facilitators to Glaucoma Medication Adherence in a Randomized Controlled Trial Intervention.
Rathinavelu JK; Muir KW; Majette NT; Woolson S; Olsen MK; Flaharty K; Newman-Casey PA; Kirshner M
Ophthalmol Glaucoma; 2023; 6(6):626-635. PubMed ID: 37343624
[TBL] [Abstract][Full Text] [Related]
9. Barriers and facilitators of medication adherence in hypertensive African Americans: a qualitative study.
Ogedegbe G; Harrison M; Robbins L; Mancuso CA; Allegrante JP
Ethn Dis; 2004; 14(1):3-12. PubMed ID: 15002917
[TBL] [Abstract][Full Text] [Related]
10. Healthcare providers' perspectives on perceived barriers and facilitators of compassion: Results from a grounded theory study.
Singh P; Raffin-Bouchal S; McClement S; Hack TF; Stajduhar K; Hagen NA; Sinnarajah A; Chochinov HM; Sinclair S
J Clin Nurs; 2018 May; 27(9-10):2083-2097. PubMed ID: 29575539
[TBL] [Abstract][Full Text] [Related]
11. Healthcare professionals' perceptions on barriers and facilitators to DMARD use in rheumatoid arthritis.
Voshaar MJH; van den Bemt BJF; van de Laar MAFJ; van Dulmen AM; Vriezekolk JE
BMC Health Serv Res; 2022 Jan; 22(1):62. PubMed ID: 35022034
[TBL] [Abstract][Full Text] [Related]
12. Factors Impacting Adherence to Diabetes Medication Among Urban, Low Income Mexican-Americans with Diabetes.
Baghikar S; Benitez A; Fernandez Piñeros P; Gao Y; Baig AA
J Immigr Minor Health; 2019 Dec; 21(6):1334-1341. PubMed ID: 30798408
[TBL] [Abstract][Full Text] [Related]
13. Working with reactant patients: are we prescribing nonadherence?
Madsen JW; McQuaid JR; Craighead WE
Depress Anxiety; 2009; 26(2):129-34. PubMed ID: 18972363
[TBL] [Abstract][Full Text] [Related]
14. Mapping patient-identified barriers and facilitators to retention in HIV care and antiretroviral therapy adherence to Andersen's Behavioral Model.
Holtzman CW; Shea JA; Glanz K; Jacobs LM; Gross R; Hines J; Mounzer K; Samuel R; Metlay JP; Yehia BR
AIDS Care; 2015; 27(7):817-28. PubMed ID: 25671515
[TBL] [Abstract][Full Text] [Related]
15. Barriers to medication adherence for the secondary prevention of stroke: a qualitative interview study in primary care.
Jamison J; Graffy J; Mullis R; Mant J; Sutton S
Br J Gen Pract; 2016 Aug; 66(649):e568-76. PubMed ID: 27215572
[TBL] [Abstract][Full Text] [Related]
16. Impact of adherence to antidepressants on healthcare outcomes and costs among patients with type 2 diabetes and comorbid major depressive disorder.
Vega C; Becker RV; Mucha L; Lorenz BH; Eaddy MT; Ogbonnaya AO
Curr Med Res Opin; 2017 Oct; 33(10):1879-1889. PubMed ID: 28644095
[TBL] [Abstract][Full Text] [Related]
17. Understanding Barriers to Glaucoma Treatment Adherence among Participants in South India.
Killeen OJ; Pillai MR; Udayakumar B; Shroff S; Vimalanathan M; Cho J; Newman-Casey PA
Ophthalmic Epidemiol; 2020 Jun; 27(3):200-208. PubMed ID: 31952462
[No Abstract] [Full Text] [Related]
18. Medication Adherence in Type 2 Diabetes Mellitus: A Qualitative Exploration of Barriers and Facilitators From Socioecological Perspectives.
Onwuchuluba EE; Oyetunde OO; Soremekun RO
J Patient Exp; 2021; 8():23743735211034338. PubMed ID: 34368436
[TBL] [Abstract][Full Text] [Related]
19. Barriers to and facilitators of antiretroviral therapy adherence in Nepal: a qualitative study.
Wasti SP; Simkhada P; Randall J; Freeman JV; van Teijlingen E
J Health Popul Nutr; 2012 Dec; 30(4):410-9. PubMed ID: 23304907
[TBL] [Abstract][Full Text] [Related]
20. Patients' perspective of disease and medication adherence for type 2 diabetes in an urban area in Bangladesh: a qualitative study.
Islam SM; Biswas T; Bhuiyan FA; Mustafa K; Islam A
BMC Res Notes; 2017 Mar; 10(1):131. PubMed ID: 28327202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
